ESTA
Establishment Labs Holdings Inc.
NASDAQ · Healthcare · Medical - Devices · CR
$74.29
+2.75%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 245.8M | 211.1M | 166.0M | 165.2M | 161.7M |
| Cost of Revenue | 72.5M | 64.8M | 56.5M | 58.2M | 55.1M |
| Gross Profit | 173.3M | 146.3M | 109.5M | 107.0M | 106.6M |
| Operating Expenses | |||||
| R&D Expense | 20.3M | 20.2M | 19.7M | 26.4M | 20.3M |
| SG&A Expense | 124.8M | 165.1M | 139.8M | 145.6M | 126.0M |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 46.9M | — | — | — | — |
| Total Operating Expenses | 192.0M | 185.3M | 159.5M | 172.0M | 146.3M |
| Cost and Expenses | 264.6M | 250.1M | 216.0M | 230.2M | 201.4M |
| Operating Income (EBIT) | (18.8M) | (39.0M) | (50.0M) | (65.0M) | (39.7M) |
| Non-Operating | |||||
| Interest Income | 144.0K | 423.0K | 1.5M | 1.0M | 87.0K |
| Interest Expense | 27.6M | 25.3M | 20.8M | 15.4M | 11.8M |
| Net Interest Income | (27.4M) | (24.8M) | (19.4M) | (14.4M) | (11.7M) |
| Other Non-Op Income/Expense | (28.7M) | (19.0M) | (34.6M) | (13.6M) | (33.2M) |
| Non-Operating Income (excl Interest) | 1.1M | (6.2M) | 13.8M | (1.8M) | 21.4M |
| EBT (Pre-Tax Income) | (47.5M) | (58.0M) | (84.6M) | (78.6M) | (72.8M) |
| Income Tax Expense | (8.6M) | (7.0M) | (32.0K) | (81.0K) | 2.4M |
| Bottom Line | |||||
| Net Income | (38.9M) | (51.1M) | (84.6M) | (78.5M) | (75.2M) |
| Earnings from Cont. Ops | (38.9M) | (51.1M) | (84.6M) | (78.5M) | (75.2M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (38.9M) | (51.1M) | (84.6M) | (78.5M) | (75.2M) |
| Per Share | |||||
| Basic EPS | ($1.31) | ($1.72) | ($3.00) | ($3.07) | ($3.08) |
| Diluted EPS | ($1.31) | ($1.72) | ($3.00) | ($3.07) | ($3.08) |
| Revenue Per Share | $8.16 | $7.13 | $5.90 | $6.45 | $6.61 |
| Shares | |||||
| Basic Shares Outstanding | 30.1M | 29.6M | 28.2M | 25.6M | 24.5M |
| Diluted Shares Outstanding | 30.1M | 29.6M | 28.2M | 25.6M | 24.5M |
| Profitability Metrics | |||||
| EBITDA | (6.7M) | (22.3M) | (56.2M) | (58.3M) | (56.9M) |
| D&A | 13.2M | 10.5M | 7.6M | 4.9M | 4.2M |
| EBIT | (19.9M) | (32.8M) | (63.8M) | (63.2M) | (61.1M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026